AI assistant
Sending…
DEXCOM INC — Director's Dealing 2014
Jun 3, 2014
30198_dirs_2014-06-03_385c3040-3804-4035-90cb-61959e55075d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-05-30
Reporting Person: TOPOL ERIC (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-30 | Common Stock | A | 7099.0 | $0.0010 | Acquired | 19306 | Direct |
| 2014-05-31 | Common Stock | S | 12207.0 | $0.0010 | Disposed | 7099 | Direct |
| 2014-05-31 | Common Stock | M | 12207.0 | $0.0010 | Acquired | 103116 | Indirect |
Footnotes
F1: Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
F2: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17